Frovatriptan Succinate Tablets — Class III drug recall D-0843-2020
Terminated recall by Par Pharmaceutical Inc., reported 2020-02-19, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of Aug
| Recall number | D-0843-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Par Pharmaceutical Inc., Chestnut Ridge, NY, United States |
| Recall initiated | 2020-02-10 |
| Classified | 2020-02-13 |
| Reported by FDA | 2020-02-19 |
| Terminated | 2020-11-17 |
| Distributed | Nationwide (US) |
| Quantity | 9,936 cartons |
| Reason classes | labeling |
| NDC | 00603-3718-34 |
| Lot numbers | 9698818 |
| Expiration dates | 2022-04-20, 2022-08-20 |
Product
Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0843-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.